Hot Features
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-28 | Dr. Thomas F. KirkLead Independent Director | 25,00k | 24,83k | Achat | 0,99 | 646,43k | 4,02% |
| 2026-05-27 | Dr. Harry KovelmanChief Medical Officer | -32,00k | 32,24k | Vente | 1,00 - 1,02 | 57,55k | -35,73% |
| 2026-05-15 | Dr. Thomas F. KirkLead Independent Director | 75,01k | 68,24k | Achat | 0,91 | 621,43k | 13,73% |
| 2026-05-14 | Horton Capital Management, LLCSociété | 201,20k | 173,91k | Achat | 0,86 - 0,89 | 2,31M | 9,54% |
| 2026-05-14 | Mr. Micah J. MitchellChief Commercial Officer | -90,23k | 77,69k | Vente | 0,86 | 16,71k | -84,38% |
| 2026-04-13 | Mr. David A. HenryCFO | -3,95k | 2,81k | Sale to Issuer | 0,71 | 309,61k | -1,26% |
| 2026-03-16 | Ms. Heather C. GetzIndependent Director | 20,00k | 13,97k | Achat | 0,70 | 131,75k | 17,90% |
| 2026-03-13 | Dr. Thomas F. KirkLead Independent Director | 72,00k | 51,11k | Achat | 0,71 | 546,43k | 15,18% |
| 2026-03-12 | Ms. Heather C. GetzIndependent Director | 70,00k | 50,96k | Achat | 0,73 | 104,32k | 203,94% |
| 2025-12-01 | Horton Capital Management, LLCSociété | 1,04M | 1,08M | Achat | 0,91 - 1,10 | 1,96M | 112,51% |
| 2025-11-20 | Dr. Thomas F. KirkLead Independent Director | 7,44k | 5,35k | Achat | 0,72 | 459,57k | 1,64% |
| 2025-11-18 | Mr. Thomas A. CrowleyIndependent Director | 4,39k | 3,23k | Achat | 0,73 - 0,77 | 53,94k | 8,85% |
| 2025-09-09 | Mr. Paul R. GudonisPresident, CEO & Chairman | -10,00k | 0,00 | Other Disposition | - | 1,01M | -0,99% |
| 2025-08-25 | Dr. Thomas F. KirkLead Independent Director | 50,00k | 57,50k | Achat | 1,15 | 444,70k | 12,67% |
| 2025-08-18 | Dr. Thomas F. KirkLead Independent Director | 50,00k | 55,00k | Achat | 1,10 | 394,70k | 14,51% |
| 2025-08-15 | Mr. Paul R. GudonisPresident, CEO & Chairman | 50,00k | 47,30k | Achat | 0,95 | 1,02M | 5,18% |
| 2025-06-30 | Dr. Harry KovelmanChief Medical Officer | -13,05k | 28,59k | Sale to Issuer | 2,19 | 42,35k | -23,56% |
| 2025-06-30 | Mr. David A. HenryCFO | -23,59k | 51,66k | Sale to Issuer | 2,19 | 304,84k | -7,18% |
| 2025-06-06 | Dr. Harry KovelmanChief Medical Officer | -5,74k | 17,06k | Sale to Issuer | 2,97 | 15,40k | -27,16% |
| 2025-06-06 | Mr. David A. HenryCFO | -8,37k | 24,87k | Sale to Issuer | 2,97 | 263,42k | -3,08% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.